DiscGenics

Description

DiscGenics is a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Founders

Flagg Flanagan

Date Founded

2007

Company Size

11-50 

TechBuzz Articles

DiscGenics Raises $50 Million for Novel Back Pain Treatment, Mark Tullis, October 21st, 2020

Buzzworthy Mentions

DiscGenics Announces Positive Interim Data on Clinical Trial of IDCT Therapy, March 4th, 2022

DiscGenics Completes Enrollment in Japanese Study, April 30th, 2021